Broadenbio Ltd., Co.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma (NCT07239986) | Broadenbio Ltd., Co. | 2025-12-01 |
| A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors (NCT06143007) | Broadenbio Ltd., Co. | 2023-10-26 |
| A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors (NCT06258408) | Broadenbio Ltd., Co. | 2022-12-29 |
Track Broadenbio Ltd., Co. automatically
Every clearance here is in the API, with alerts when new ones post.